Under incubation with BMP-2, ALK5 expression showed a steady increase, from day 19 onward, and pASCs treated additionally with BMP-2 showed a significant induction of ALK5 expression in comparison to the OM group (p < 0.01) (Figure 6). Here, BMP2 is linked to ocular melanoma.